Bio Spectra

Description

ATTITUDE® natural care is a vegan toothpaste formulated with fluoride, designed to promote fresh breath. This product is EWG VERIFIED, ensuring adherence to strict environmental and health standards. The toothpaste features a peppermint flavor and incorporates Super Leaves for enhanced efficacy. Each tube contains 120 grams (4.2 ounces) and is identified by NPN 80104880.

Uses and Indications

This drug is indicated for the prevention and treatment of dental caries (cavities) and tooth decay. It provides effective fluoride protection, which aids in the remineralization of tooth enamel and helps to rebuild weak spots in the enamel structure. Additionally, this drug protects teeth from acid erosion, contributing to overall dental health.

Dosage and Administration

The product is intended for oral use only and should not be swallowed. It is recommended that this product be utilized as part of a comprehensive oral health program, which includes regular flossing and routine dental check-ups.

For optimal results, individuals should brush their teeth thoroughly for a minimum of 1 minute, twice daily, preferably after each meal, or as directed by a dentist.

In children under 6 years of age, only a pea-sized amount should be used, and they must be supervised to ensure proper brushing technique and to prevent swallowing.

Prior to use in children under 2 years of age, consultation with a dentist or healthcare professional is advised.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance or contact with a poison control center is advised.

Warnings and Precautions

It is imperative to keep this medication out of the reach of children. In the event of accidental ingestion, immediate action is required. Healthcare professionals should advise caregivers to contact a poison control center or seek medical assistance without delay.

Additionally, it is essential to monitor patients for any adverse effects associated with the use of this medication. Regular assessments and appropriate laboratory tests may be necessary to ensure patient safety and therapeutic efficacy.

Side Effects

Patients should be advised to keep the product out of reach of children. In the event of accidental ingestion, it is imperative to contact a poison control center or seek medical assistance immediately. This warning underscores the potential seriousness of the situation and the need for prompt action to ensure safety.

Drug Interactions

There are no specific drug interactions identified for this medication. Additionally, no laboratory test interactions have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Bio Spectra (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be kept out of reach of children. In the event of accidental ingestion, it is imperative to contact a poison control center or seek medical assistance immediately.

For children under 6 years of age, only a pea-sized amount should be used, and they must be supervised during brushing to ensure proper technique and to prevent swallowing. Additionally, it is recommended to consult a dentist or healthcare professional prior to use in children under 2 years of age.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no specific information available regarding the use of this drug during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while using this medication.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. The effects on breastfed infants have not been established, and further data may be necessary to inform clinical decisions.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the event of an overdosage, immediate action is crucial. If the substance is swallowed, it is imperative to contact a poison control center or seek medical assistance without delay.

Healthcare professionals should be aware that prompt intervention can significantly influence the outcome of an overdosage situation. Symptoms may vary depending on the specific substance involved, and monitoring for any adverse effects is essential.

Management procedures should include a thorough assessment of the patient's condition, including vital signs and any presenting symptoms. Supportive care may be necessary, and specific treatment protocols should be followed based on the substance ingested and the severity of the overdosage.

In all cases, the guidance of a poison control center can provide valuable information for the appropriate management of the situation.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children. It is important to emphasize that if the medication is swallowed, patients should immediately contact a poison control center or seek medical assistance. This precaution is vital to ensure the safety and well-being of children who may inadvertently access the medication.

Storage and Handling

The product is supplied in a tube format, with specific handling and storage requirements to ensure its integrity and effectiveness. It should be stored at room temperature, away from extreme temperatures. The tube must be kept tightly closed when not in use to prevent contamination and maintain product quality. Freezing the product is not permitted, as it may compromise its formulation. Additionally, it is advised to discard the product after opening if it is not used within a specified time frame, which is not detailed in the provided information.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Bio Spectra, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)